IGO Limited

The Business

IGO's economic interest in Greenbushes runs through three layers: IGO owns 49% of Tianqi Lithium Energy Australia (TLEA), which owns 51% of Windfield Holdings, which in turn owns Talison and the Greenbushes mine outright. The net effect is a 24.99% indirect, non-controlling stake in a tier-one asset that IGO does not operate and cannot direct. Since the closure of the Nova nickel mine, IGO has no operating revenue of its own. It is now a financial holding company waiting on dividends from a joint venture run by its partners.

Recent Performance

Spodumene prices recovered from roughly US$783 a tonne a year ago to US$1,443 a tonne currently, an 84% rebound that lifted Greenbushes' FY26 revenue by 60% off that depressed base. IGO's share price has climbed alongside the commodity, trading near multi-year highs despite receiving zero cash dividends from TLEA to date. The re-rating reflects sector sentiment on lithium scarcity, not any improvement in what IGO actually collects.

Outlook

Greenbushes' output should grow from 1,410kt toward roughly 1,900kt as the CGP3 expansion ramps, a structural, multi-year volume trend. Working against it is an expected normalisation in spodumene pricing from current elevated levels toward a lower terminal level, a cyclical force that we expect to compress EBITDA margins over the remainder of the decade even as tonnes shipped keep rising. TLEA dividends to IGO are not expected before FY29, and even then are likely to be modest relative to IGO's market capitalisation. Earnings capacity at the mine level should keep growing in absolute terms, but the pace at which that translates into cash reaching IGO shareholders remains slow and uncertain.

Key Risks

A sustained spodumene price collapse would meaningfully compress the attributable earnings IGO relies on to eventually justify a dividend, driven by new supply additions out of Africa and China that could keep prices depressed for an extended period. This is the single largest swing factor in the outlook and a genuine possibility given capacity commissioning underway in the DRC and Zimbabwe. Separately, Windfield's substantial debt load and ongoing losses at the Kwinana refinery could structurally delay TLEA distributions well beyond current expectations, a risk IGO's minority, non-controlling position gives it no ability to force its way around. A further risk sits in capital allocation: IGO's cash reserves and stated ambitions to build a copper portfolio create the possibility of a deal struck at the wrong point in a commodity cycle, echoing the timing of the 2021 TLEA acquisition.

What to Watch

• Feb 2028 H1 FY28 result — the thesis-defining event, confirming whether Windfield's debt is falling fast enough to support the first TLEA dividend.
• 2-3 years Spodumene sustaining at materially higher levels for an extended period — the clearest signal that scarcity pricing is structural rather than cyclical.
• 12-18 months Spodumene falling back toward multi-year lows — would confirm the cyclical case and remove near-term dividend prospects.

Company Description

IGO's value sits almost entirely in its 24.99% indirect interest in Greenbushes, held through TLEA and Windfield alongside Chinese processor Tianqi Lithium and US major Albemarle. Within the same TLEA structure sits Kwinana, a lithium hydroxide refinery that has run at a loss since commissioning. IGO's former Nova nickel-copper-cobalt mine, once its main operating asset, closed in FY27, ending a decade of consolidated production revenue. The remaining internal growth option is BioHeap, an early-stage copper bioleaching technology aimed at unlocking low-grade deposits, alongside modest exploration spend.

Where the Growth Is

The only growth driver that matters is Greenbushes' CGP3 expansion, lifting production from 1,410kt toward 1,900kt and generating a meaningful step-up in EBITDA attributable to IGO's stake. That volume growth is a structural, multi-year trend, but it is being offset by spodumene price normalisation, a cyclical force pulling the other way. The payoff for IGO shareholders is modest: TLEA dividends are expected to start only from FY29, and at a level small relative to IGO's market capitalisation.

Competitive Position

Greenbushes' cost position is genuinely wide and durable. It is the world's lowest-cost hard-rock lithium mine, with a resource base and mine life that should keep it running profitably through commodity cycles that shut down higher-cost African and Chinese lepidolite supply. That advantage should hold for the better part of a decade. The problem is not the asset, it is IGO's access to it. A 24.99% indirect, non-controlling stake means IGO cannot force distributions, direct capital allocation, or influence how joint venture partners TLC and Albemarle prioritise cash. The moat protects Greenbushes' earnings power; it does very little to protect IGO shareholders' claim on those earnings.

Management & Capital Discipline

The defining data point on capital allocation is the 2021 TLEA acquisition, made near the top of the lithium cycle for roughly $1.9bn at around 10 times EBITDA. Capital decisions since have been comparatively small and largely untested. Management has been candid about the uncertainty around BioHeap and the challenges at Kwinana, a level of transparency that is worth noting. Less reassuring: two chief financial officer departures within six months point to governance instability at a time when disciplined capital allocation matters most for a holding company with limited operating control.

Financial Position

IGO carries no net debt at the corporate level and holds sufficient cash and undrawn facilities to fund several years of corporate overhead even without any TLEA dividends. That gives the balance sheet genuine resilience against a prolonged downturn or a delay in distributions. The risk is not solvency, it is opportunity cost: cash sitting idle while shareholders wait for a dividend stream that may not begin until FY29, and the temptation that liquidity creates for M&A at the wrong point in the cycle.